Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
ARTICLE | Financial News

Ascletis ends first trading week on downturn

August 3, 2018 5:36 PM UTC

Ascletis Pharma Inc. (HKSE:1672) sank HK$1.84 (16%) to HK$10.02 on Friday, ending its first week of trading down 28% from its IPO price of HK$14.

This week, Ascletis became the first biotech to go public on the Hong Kong exchange since Hong Kong Exchanges and Clearing Ltd. (HKEX) created a new prerevenue chapter, opening the door for biotechs to list (see "First Out the Gate")...

Get Unlimited Access
Continue reading with a free trial.
Or Purchase This Article